Nanollose Limited (NC6.AX)
AUD 0.04
(8.11%)
AUD 0.04
(8.11%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -1.15 Million AUD | 14.05% |
| 2023 | -1.34 Million AUD | 14.1% |
| 2022 | -1.56 Million AUD | -68.25% |
| 2021 | -931.04 Thousand AUD | 24.64% |
| 2020 | -1.23 Million AUD | 38.35% |
| 2019 | -2 Million AUD | -15.82% |
| 2018 | -1.73 Million AUD | -110.91% |
| 2017 | -820.34 Thousand AUD | -8180.47% |
| 2016 | -9907.00 AUD | -377.68% |
| 2015 | -2074.00 AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -1.15 Million AUD | 14.05% |
| 2024 Q2 | -516.9 Thousand AUD | -41.32% |
| 2024 Q4 | -639.64 Thousand AUD | -23.75% |
| 2023 Q2 | -979.87 Thousand AUD | 0.0% |
| 2023 Q4 | -365.78 Thousand AUD | 0.0% |
| 2023 FY | -1.34 Million AUD | 14.1% |
| 2022 Q2 | -988.91 Thousand AUD | 0.0% |
| 2022 FY | -1.56 Million AUD | -68.25% |
| 2022 Q4 | -577.59 Thousand AUD | 0.0% |
| 2021 Q4 | -489.96 Thousand AUD | 0.0% |
| 2021 Q2 | -441.07 Thousand AUD | 0.0% |
| 2021 FY | -931.04 Thousand AUD | 24.64% |
| 2020 Q2 | -588.26 Thousand AUD | 0.0% |
| 2020 FY | -1.23 Million AUD | 38.35% |
| 2020 Q4 | -647.22 Thousand AUD | 0.0% |
| 2019 FY | -2 Million AUD | -15.82% |
| 2019 Q4 | -972.21 Thousand AUD | 0.0% |
| 2019 Q2 | -1.03 Million AUD | 0.0% |
| 2018 FY | -1.73 Million AUD | -110.91% |
| 2018 Q4 | -896.99 Thousand AUD | 0.0% |
| 2018 Q2 | -833.22 Thousand AUD | 0.0% |
| 2017 Q4 | -360.14 Thousand AUD | 0.0% |
| 2017 Q1 | -230.1 Thousand AUD | 0.0% |
| 2017 FY | -820.34 Thousand AUD | -8180.47% |
| 2017 Q3 | - AUD | 100.0% |
| 2017 Q2 | -460.2 Thousand AUD | -100.0% |
| 2016 FY | -9907.00 AUD | -377.68% |
| 2015 FY | -2074.00 AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | 78.508% |
| Acrux Limited | -5.8 Million AUD | 80.059% |
| Actinogen Medical Limited | -13.04 Million AUD | 91.134% |
| AnteoTech Limited | -8.88 Million AUD | 86.977% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 78.893% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 86.776% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 20.306% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 93.952% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 74.319% |
| Avecho Biotechnology Limited | -3.43 Million AUD | 66.346% |
| Bio-Gene Technology Limited | -2.4 Million AUD | 51.994% |
| Biome Australia Limited | -1.67 Million AUD | 30.754% |
| Biotron Limited | -3.43 Million AUD | 66.345% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 91.661% |
| BTC Health Limited | 1.05 Million AUD | 209.596% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 90.77% |
| CSL Limited | 2.64 Billion AUD | 100.044% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 97.267% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 103.245% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 88.131% |
| Dimerix Limited | -17.07 Million AUD | 93.227% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 116.606% |
| Hexima Limited | -933.87 Thousand AUD | -23.845% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | 59.622% |
| Immuron Limited | -6.93 Million AUD | 83.328% |
| Immutep Limited | -39.89 Million AUD | 97.101% |
| Imugene Limited | -149.68 Million AUD | 99.227% |
| Invex Therapeutics Ltd | -1.64 Million AUD | 29.556% |
| Memphasys Limited | -4.44 Million AUD | 73.963% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 100.736% |
| Noxopharm Limited | -3.57 Million AUD | 67.677% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 456.73% |
| Nyrada Inc. | -1.38 Million AUD | 16.568% |
| Orthocell Limited | -7.18 Million AUD | 83.894% |
| PharmAust Limited | -9.03 Million AUD | 87.195% |
| Patrys Limited | -3.53 Million AUD | 67.321% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 98.028% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 81.861% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 85.961% |
| PYC Therapeutics Limited | -37.72 Million AUD | 96.934% |
| Race Oncology Limited | -13.81 Million AUD | 91.631% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 97.588% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 93.452% |
| Starpharma Holdings Limited | -8.16 Million AUD | 85.835% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 122.194% |
| Tissue Repair Ltd | -4.13 Million AUD | 72.051% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 96.837% |